PAVmed (PAVM) Cash from Financing Activities (2015 - 2025)

PAVmed has reported Cash from Financing Activities for 10 years, with the latest figure at -$2000.0 in Q3 2025.

• For the quarter ending Q3 2025, Cash from Financing Activities changed N/A year-over-year to -$2000.0; the trailing twelve-month figure through Dec 2025 stood at $5.6 million (down 84.6% YoY), and the FY2025 full-year result was $5.6 million, down 82.13% from the prior year.
• Cash from Financing Activities for Q3 2025 stood at -$2000.0, down from $2.5 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $60.1 million in Q4 2021, with the low at -$2000.0 in Q3 2025.
• Average Cash from Financing Activities over 5 years is $11.7 million, with a median of $2.8 million recorded in 2025.
• Year-over-year, Cash from Financing Activities plunged 99.87% in 2022 and surged 7787.34% in 2023.
• Tracing PAVM's Cash from Financing Activities over 5 years: stood at $60.1 million in 2021, then sank by 99.87% to $80000.0 in 2022, then soared by 6510.0% to $5.3 million in 2023, then slumped by 93.76% to $330000.0 in 2024, then tumbled by 100.61% to -$2000.0 in 2025.
• The last three Cash from Financing Activities figures came in at -$2000.0 (Q3 2025), $2.5 million (Q2 2025), and $3.1 million (Q1 2025), per Business Quant data.

Peer Comparison